Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Amerika
Aethlon Medical Inc
Nieuws
Aethlon Medical Inc
AEMD
NAS
: AEMD
| ISIN: US00808Y3071
30/04/2024
1,380 USD
(+0,73%)
(+0,73%)
30/04/2024
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Insiders
Technische analyse
TA
Toon enkel gratis nieuws
21 februari 2024 ·
Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices
· Persbericht
14 februari 2024 ·
Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update
· Persbericht
7 februari 2024 ·
Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024
· Persbericht
6 november 2023 ·
Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023
· Persbericht
10 oktober 2023 ·
Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in Oncology
· Persbericht
4 oktober 2023 ·
Aethlon Announces Reverse Stock Split
· Persbericht
30 augustus 2023 ·
Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference
· Persbericht
10 augustus 2023 ·
Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate Update
· Persbericht
3 augustus 2023 ·
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023
· Persbericht
24 juli 2023 ·
Aethlon Medical Signs Collaboration Agreement with 34 Lives to Evaluate the Ability of the Hemopurifier® to Expand the Utility of Unused, Donated Kidneys for Transplant
· Persbericht
6 juli 2023 ·
Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directors
· Persbericht
28 juni 2023 ·
Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update
· Persbericht
22 juni 2023 ·
Aethlon Medical to Release Fourth Quarter and Year End Financial Results and Host Conference Call on June 28, 2023
· Persbericht
21 juni 2023 ·
Aethlon Medical Announces Investigation of the Hemopurifier® for Use in Organ Transplantation
· Persbericht
14 juni 2023 ·
Aethlon Medical to Participate in the Healthcare Virtual Conference Presented by Maxim Group and Hosted by M-Vest
· Persbericht
1 juni 2023 ·
Aethlon Medical to Present at the 13th Annual LD Micro Invitational
· Persbericht
22 mei 2023 ·
Aethlon Medical Receives Ethics Board Approval to Add Second Site to its Ongoing Clinical Trial of its Hemopurifier® to Treat Severe COVID-19 in India
· Persbericht
13 februari 2023 ·
Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update
· Persbericht
31 januari 2023 ·
Aethlon Medical to Present at Sequire Biotechnology Conference on February 2nd, 2023
· Persbericht
30 januari 2023 ·
Aethlon Medical Announces Contract with NAMSA to Advance Hemopurifier Clinical Programs in Cancer
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe